Inozyme Pharma Inc. (INZY)
1.40
0.04 (2.94%)
At close: Jan 28, 2025, 1:44 PM
Income Statement (Annual)
Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 |
| Revenue | n/a | n/a | n/a | n/a | n/a | n/a |
| Cost of Revenue | 1.29M | 1.18M | 1.05M | 217.00K | 83.00K | 26.00K |
| Gross Profit | -1.29M | -1.18M | -1.05M | -217.00K | -83.00K | -26.00K |
| Operating Income | -75.64M | -68.67M | -56.65M | -57.04M | -20.81M | -11.59M |
| Interest Income | 7.84M | 1.93M | 211.00K | 370.00K | 1.11M | 284.00K |
| Pretax Income | -71.17M | -67.06M | -56.62M | -56.42M | -19.72M | -6.96M |
| Net Income | -71.17M | -65.45M | -56.41M | -55.84M | -18.62M | -6.96M |
| Selling & General & Admin | 20.80M | 20.83M | 18.93M | 10.55M | 4.59M | 3.49M |
| Research & Development | 54.05M | 47.85M | 37.72M | 46.49M | 16.22M | 8.10M |
| Other Expenses | n/a | -319.00K | -189.00K | 247.00K | -24.00K | 4.34M |
| Operating Expenses | 75.64M | 68.67M | 56.65M | 57.04M | 20.81M | 11.59M |
| Interest Expense | 3.33M | n/a | n/a | n/a | n/a | n/a |
| Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a |
| Cost & Expenses | 75.64M | 68.67M | 56.65M | 57.04M | 20.81M | 11.59M |
| Income Tax | n/a | -1.61M | -211.00K | -587.00K | -1.11M | 4.63M |
| Shares Outstanding (Basic) | 51.84M | 37.76M | 23.56M | 23.38M | 15.16M | 15.14M |
| Shares Outstanding (Diluted) | 51.84M | 37.76M | 23.56M | 23.38M | 15.16M | 15.14M |
| EPS (Basic) | -1.37 | -1.73 | -2.39 | -2.39 | -1.23 | -0.46 |
| EPS (Diluted) | -1.37 | -1.73 | -2.39 | -2.39 | -1.23 | -0.46 |
| EBITDA | -74.81M | -65.88M | -55.97M | -56.82M | -20.72M | -11.57M |
| Depreciation & Amortization | 833.00K | 1.18M | 1.05M | 217.00K | 83.00K | 26.00K |